Sartorius to commercialize Qkine growth factors and cytokines as part of a complete workflow solution for stem cell and organoid research Cell type-specific application data on Sartorius instruments streamline process and speed up time to results This collaboration supports a larger initiative to enable rapid advancement in the science of advanced cell models Cambridge, […]
Harnessing its automated cell culturing and digital technology to overcome intractable diseases Tokyo – Hitachi, Ltd. (TSE: 6501, “Hitachi”) announced that it has entered a strategic framework collaboration agreement with the world-renowned medical research institution, Brigham and Women’s Hospital (BWH), a founding member of the Mass General Brigham healthcare system and a teaching affiliate of […]
Additional 400,000 sq.ft. at GenScript’s cGMP facility in Zhenjiang, China gives biopharma companies and gene/cell therapeutic discovery startups fast access to synthetic CRISPR sgRNA and non-viral single and double-stranded DNA payloads PISCATAWAY, N.J. — GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity for sgRNA […]
Seoul, South Korea – MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of Food and Drug Safety (MFDS). This marks another significant step for MGI into the South Korean market […]
SOPHiA DDMTM Platform will bring next-generation sequencing in-house and help further research on hematologic malignancies BOSTON and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Centre Hospitalier de Bastia is live on the SOPHiA DDM™ Platform. Centre Hospitalier de Bastia, a general hospital located in the city […]
QIAGEN expands next-generation sequencing portfolio with QIAseq Normalizer kits Normalizes various library types over a broad range of concentrations in only 30 minutes QIAseq kits have processed more than four million NGS samples Venlo, the Netherlands – QIAGEN today announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective […]
Latest software updates support FDA 21 CFR Part 11 compliance and a full IQ/OQ package for pharmaceutical quality assurance Additional functionalities extend Cyto-Mine applications into manufacturing operations Cambridge, UK: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced updates to its flagship platform, Cyto-Mine®, enabling it to […]
During May and June 2023 several sub-sales and distribution agreements were signed between Sartorius and BICO companies CELLINK, Advanced BioMatrix (ABM) and Dispendix. In addition, R&D project agreements with CELLINK, MatTek, ABM, and Cellenion were also signed. Overall, this prominent long-term partnership strengthens both BICO’s commercial agenda as well as our overall business. As announced […]
Ann Arbor, MI – Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics. This partnership expands access to Navinci’s portfolio of proximity ligation-based solutions for spatial proteomics to US- and Canada-based researchers through Cayman’s strong customer base and […]
Shimadzu Corporation has collaborated in developing Exorapid-qIC, an immunochromatography kit for extracellular vesicles (CD9) to be launched for advanced domestic sales on July 25 by Dai Nippon Toryo Co., Ltd. Exorapid-qIC is the world’s first immunochromatography reagent kit that targets exosomes, which are a type of extracellular vesicle (EV). Exorapid-qIC comes with “gold nanoplate-labeled antibodies,” […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
